UKIPO cancels SPC extension at owner’s request

16-06-2020

Rory O'Neill

UKIPO cancels SPC extension at owner’s request

Willy Barton / Shutterstock.com

The UK Intellectual Property Office has agreed to revoke an extension to a supplementary protection certificate (SPC) for immunosuppressant tocilizumab, at the request of the owners.


UKIPO, Chugai, SPC, immunosuppressant, arthritis, paediatrics, marketing exclusivity, EMA, protection, tocilizumab, European Commission, RoActemra

LSIPR